Risperidone-induced hepatotoxicity in children and adolescents? A chart review study

Journal of Child and Adolescent Psychopharmacology

Volumn 9, Issue 2, 1999, Pages 93-98

  Szigethy, Eva ^a   Wiznitzer, Max ^a   Branicky, Lisa A ^a   Maxwell, Kathleen ^a   Findling, Robert L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESEARCH; DRUG USE; FEMALE; HUMAN; LIVER FUNCTION; MALE;

EID: 0032776757     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1999.9.93     Document Type: Article

References (22)

1. Armenteros JL, Whitaker AH, Welikson M, Stedge DJ, Gorman J: Risperidone in adolescents with schizophrenia: An open pilot study. J Am Acad Child Adolesc Psychiatry 36:694-700, 1997
2. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE: Idiopathic steatohepatitis in childhood: A multicenter retrospective study. J Pediatr 127:700-704, 1995
3. Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Isabelle A, Beauclair L, Arnott W: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13:24-40, 1993
4. Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peurkens J, Heulen S. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: A multicentre double-blind comparative study. Acta Psychiatr Scand 85:295-305, 1992
5. Findling RL, Maxwell K, Wiznitizer M: An open clinical trial of risperidone in young children with autistic disorder. Psychopharmacol Bull 33:155-159, 1997
6. th Annual Meeting, Las Croabas, Peurto Rico, December, 1998
7. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, Brunetti F, Rubino A: Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sciences 42:1468-1432, 1997
8. Fras I, Major LF: Clinical experience with risperidone [letter]. J Am Acad Child Adolesc Psychiatry 34:833, 1995
9. Grcevich SJ, Findling RL, Rowane WA, Friedman L, Schulz SC: Risperidone in the treatment of children and adolescents with schizophrenia: A retrospective study. J Child Adolesc Psychopharmacol 6:251-257, 1996
10. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM: Physical growth: National Center for Health Statistics percentiles. American Journal of Clinical Nutrition 32:607-629, 1979
11. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM: Standardized percentile curves of body-mass index for children and adolescents. AJDC 145:259-263, 1991
12. Janssen PAJ, Niemegeers CJE, Awouters F, Schellekens KHL, Megems AAHP, Meert TF: Pharmacology of risperidone (R64766) a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685-693, 1988
13. Kumra S, Herion D, Jacobsen LK, Briguglia C, Grothe D: Case study: Risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 36:701-705, 1997
14. Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, McDougle CJ, Leckman JF: Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report. J Am Acad Child Adolesc Psychiatry 34:1147-1152, 1995
15. Mandoki MW: Risperidone treatment of children and adolescents: Increased risk for extrapyramidal side effects? J Child Adolesc Psychopharmacol 5:49-67, 1995
16. Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825-835, 1994
17. McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ: Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. J Am Acad Child Adolesc Psychiatry 36:685-693, 1997
18. Moran JR, Chistian FK, Halter SA, Greene HL: Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol 78:374-377, 1983
19. Noguchi H, Tazawa Y, Nishinomiya F, Takada G: The relationship between serum transaminase activities and fatty livers in children with simple obesity. Acta Ped Japonica 37:621-625, 1995
20. Tazawa Y, Noguchi H, Nishinomiya F, Takada G: Effect of weight change on serum transaminase activities in obese children. Acta Ped Japonica 39:210-214, 1997
21. 2C serotonin receptors. Nature 374:542-546, 1995
22. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, DeVincenzo A: Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 125:239-241, 1997